Electrical stimulation treatment for visual field defects in glaucoma patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot study evaluates the safety and effectiveness of transcorneal electrical stimulation (TES) using the OkuStim 2 System for treating visual field defects in patients with various forms of glaucoma. Participants will be randomly assigned to receive either TES or a sham treatment while continuing their usual pressure-lowering eye drops. The study aims to determine if TES can slow the progression of visual field loss over an 18-month treatment period, with weekly sessions lasting 30 minutes. The study is designed as a double-masked, randomized, sham-controlled trial to ensure unbiased results.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Willingness to participate in the study, the subjects signed and dated informed consent must be submitted before the start of the screening
2. Age ≥ 40 years
3. Primary open-angle glaucoma, pseudoexfoliation glaucoma, pigment dispersion glaucoma or normal tension glaucoma (according to the EGS criteria) in the study eye
4. Current progression in perimetry of at least 1.5 dB per year in the study eye and mean defect (MD) in the study eye between ≥ 6 and ≤ 12 dB (Octopus visual field) or ≤ -6 and ≥ -12 dB (Humphrey visual field) in the screening examination as the mean value of the two visual field examinations carried out as part of the screening (permitted deviation maximum 2 dB)
5. Visual acuity ≥ 0.2 decimal in the study eye (corresponds to a visual acuity of 0.7 logMAR)
6. The patient must master home stimulation after extensive training.
7. Ability of subject to understand the scope, significance and individual consequences of participation in the study
8. Ability of subject to give consent
9. If both eyes meet the inclusion/exclusion criteria, the eye with the higher MD is selected as the study eye. If the MD is the same in both eyes, the eye with the worse visual acuity will be selected as the study eye. If there is no difference between the eyes, the right eye will be selected as the study eye
10. Negative serum or urine pregnancy test at screening in women of childbearing potential. Participants are considered to be of nonchildbearing potential if they are postmenopausal and have not menstruated for at least 12 months prior to screening or if they are surgically sterile
11. Women of childbearing potential must agree to be abstinent or to use highly effective methods of contraception that result in a failure rate of less than 1% per year. This applies consistently throughout the duration of the treatment once you have given your consent to participate in the study.

Exclusion Criteria:

1. Neovascularisations of any origin in the study eye
2. Condition after arterial or venous occlusions in the study eye
3. Condition after intraocular surgery in the last 3 months before the screening examination in the study eye
4. Acute (intra)ocular inflammation in any eye
5. Non-proliferative or proliferative diabetic retinopathy in the study eye
6. Condition after retinal detachment in the study eye
7. Dry age-related macular degeneration affecting the visual field in the study eye
8. Exsudative age-related macular degeneration in the study eye
9. Macular edema of any origin in the study eye
10. Other relevant retinal diseases in the study eye
11. Any form of corneal degeneration that limits vision in the study eye
12. Any disease other than glaucoma affecting the central 30° visual field in the study eye
13. No cataract surgery or other eye surgery may be planned for the patient in the study eye during the duration of the study (except laser trabeculoplasty)
14. Patients with active implants
15. General illnesses that are difficult to control/adjust and which, in the opinion of the investigator, could jeopardize regular study routines
16. Poor general condition according to the investigators assessment
17. Mental illness or dementia, that, in the opinion of the investigator, reduces the understanding of the study procedures and use of the Okustim 2 System
18. Simultaneous participation in another interventional study or past interventions whose effect may still be ongoing (30 days)
19. Breastfeeding women
20. Patients unable to consent
21. Previous enrolment in the TES-GPS study
22. Contraindications to the use of OkuStim 2 such as allergies/hypersensitivity to silver

Where it's running

• Augenklinik und Poliklinik der Universitätsmedizin Mainz, Johannes Gutenberg-Universität Mainz
  Mainz, Germany Recruiting

Study contacts

• Principal investigator: Katrin Lorenz, Prof. — Augenklinik und Poliklinik der Universitätsmedizin Mainz, Johannes Gutenberg-Universität Mainz
• Study coordinator: Katrin Lorenz, Prof.
• Email: katrin.lorenz@unimedizin-mainz.de
• Phone: +49 6131 174069

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Direct selective laser trabeculoplasty to lower eye pressure in untreated open-angle glaucoma

  This study will try direct selective laser trabeculoplasty (DSLT) to lower eye pressure by more than 20% without glaucoma medications over six months in adults newly diagnosed with open-angle glaucoma or ocular hypertension.

  Recruiting Shafer Vision Institute · Plymouth Meeting, Pennsylvania · NCT07076303

• Home IOP telemonitoring with smartphone support for open-angle glaucoma

  This trial tests whether home intraocular pressure monitoring plus a smartphone-based management plan helps people with newly diagnosed open-angle glaucoma control eye pressure better than a smartphone-based plan alone.

  Recruiting The University of Hong Kong · Wong Chuk Hang · NCT05940623

• Comparing XEN Glaucoma Gel Stent and Trabeculectomy for Glaucoma Treatment

  This study is testing whether a new minimally invasive glaucoma implant works better than traditional surgery for improving vision in people with open angle glaucoma.

  Recruiting Paracelsus Medical University · Salzburg · NCT05439161

• Assessing the Glycocalyx in Patients with Primary Open-angle Glaucoma

  This study is testing a special imaging technique to see if the tiny blood vessels in people with primary open-angle glaucoma are working properly compared to those without eye problems.

  Recruiting Fondation Ophtalmologique Adolphe de Rothschild · Paris · NCT05264818

• Balance training for people with glaucoma

  A randomized study tests whether a structured eight-week balance program helps adults with glaucoma improve balance, reduce fall risk, and lessen fear of falling.

  Recruiting Kanuni Sultan Suleyman Training and Research Hospital · Küçükçekmece, Istanbul · NCT07910955

• Eye drops Rhopressa vs Timolol to protect nerve cells in glaucoma

  In adults with open-angle glaucoma, this study tests whether Rhopressa helps preserve retinal nerve cells better than Timolol while both lower eye pressure.

  Recruiting Phase 4 Indiana University · Bloomington, Indiana · NCT07847073

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.